Solithromycin
| CAS No. | 760981-83-7 | Cat. No. | BCP14186 |
| Name | Solithromycin | ||
| Synonyms | CEM101; CEM-101; CEM 101; OP1068; OP1068; OP-1068; | ||
| Formula | C43H65FN6O10 | M. Wt | 845.01 |
| Description | Solithromycin, also known as CEM-101 and OP-1068, is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections. It is expected to be the first macrolide antibiotic available in intravenous, oral, and pediatric suspension formulations in over 20 years. Solithromycin exhibits excellent in vitro activity against a broad spectrum of Gram-positive respiratory tract pathogens, including macrolide-resistant strains. Solithromycin has activity against a wide variety of pathogens, and further research is being conducted for other infections. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.